[3] Triple-negative breast cancer (TNBC), which is clinically defined by the absence of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), contributes to an approximate 15–20% of all breast cancer cases. This evidence concerns the gene ERBB2 and breast carcinoma.